JonesTrading Maintains Cassava Sciences(SAVA.US) With Hold Rating
JonesTrading Keeps Their Hold Rating on Cassava Sciences (SAVA)
Cassava Sciences Analyst Ratings
H.C. Wainwright Maintains Cassava Sciences(SAVA.US) With Buy Rating, Maintains Target Price $116
H.C. Wainwright Upgrades Cassava Sciences(SAVA.US) to Buy Rating, Announces Target Price $116
Cassava Sciences Price Target Announced at $116.00/Share by HC Wainwright & Co.
Cassava Sciences Analyst Ratings
Cassava Sciences Upgraded to Buy From Neutral at H.C. Wainwright
Cassava Sciences Analyst Ratings
H.C. Wainwright Maintains Cassava Sciences(SAVA.US) With Hold Rating
JonesTrading Keeps Their Hold Rating on Cassava Sciences (SAVA)
Cassava Sciences Analyst Ratings
Cassava Sciences Analyst Ratings
H.C. Wainwright Sticks to Their Hold Rating for Cassava Sciences (SAVA)
Cassava Sciences Analyst Ratings
Cassava Sciences (SAVA) Was Downgraded to a Hold Rating at H.C. Wainwright
Analysts Offer Insights on Healthcare Companies: Aroa Biosurgery Ltd (AU:ARX), Cassava Sciences (SAVA) and Amplifon S.p.A. (GB:0N61)
Cassava Sciences Analyst Ratings
Cassava Sciences Progresses in Phase 3 Trials, Secures Strong Cash Position: A Buy Rating Justified
Cassava Sciences Analyst Ratings